<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Cephalexin - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Cephalexin</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Antibiotics / Antivirals</div>
      <h1>Cephalexin</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Cephalexin 500mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Skin and soft tissue infections (uncomplicated; cellulitis, abscesses when oral appropriate)</strong>
            <ul>
              <li>500 mg PO every 6 hours OR 1 g (2 x 500 mg) PO every 12 hours</li>
              <li>Duration typically 5–10 days depending on severity/response</li>
            </ul>
          </li>
          <li><strong>Streptococcal pharyngitis (when beta-lactam appropriate and penicillin allergy/alternative needed)</strong>
            <ul>
              <li>500 mg PO every 12 hours for 10 days</li>
            </ul>
          </li>
          <li><strong>Uncomplicated UTI (cystitis; when appropriate for local resistance patterns)</strong>
            <ul>
              <li>500 mg PO every 6 hours OR 1 g PO every 12 hours for 7 days (or per local guidance)</li>
            </ul>
          </li>
          <li><strong>Respiratory tract infections (when appropriate pathogen coverage)</strong>
            <ul>
              <li>500 mg PO every 6 hours; duration varies by indication (typically 5–10 days)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Susceptible skin and soft tissue infections (S. aureus, Streptococcus spp., when MSSA coverage appropriate)</li>
          <li>Streptococcal pharyngitis (alternative to penicillin)</li>
          <li>Uncomplicated urinary tract infections (appropriate susceptibility)</li>
          <li>Selected respiratory tract infections (otitis media, sinusitis, CAP when pathogen appropriate)</li>
          <li>Bone and joint infections (when susceptible organism and oral therapy appropriate)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>History of immediate hypersensitivity to cephalosporins</li>
          <li>History of severe (anaphylaxis/severe cutaneous reaction) penicillin allergy: use caution; cross-reactivity risk ~1–3% (assess individual history/risk)</li>
          <li>Renal impairment: dose adjustment required when CrCl &lt;30 mL/min (follow product monograph or local guidance)</li>
          <li>C. difficile-associated diarrhea risk: reassess if significant diarrhea develops during or after therapy</li>
          <li>Pregnancy/lactation: generally considered safe when indicated; consult product monograph for specific guidance</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>GI upset (diarrhea, nausea, abdominal pain)</li>
          <li>Hypersensitivity reactions (rash, urticaria; rarely anaphylaxis)</li>
          <li>C. difficile-associated diarrhea (important but uncommon)</li>
          <li>Vaginitis/yeast infections</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>May take with or without food; taking with food may reduce GI upset</li>
          <li>Take at evenly spaced intervals to maintain blood levels</li>
          <li>Counsel: finish the prescribed course unless told otherwise; do not share leftover antibiotics</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response within 48–72 hours (symptoms, fever, local signs of infection)</li>
          <li>Allergy/rash: stop and seek help if signs of severe reaction or anaphylaxis</li>
          <li>Diarrhea severity (consider C. difficile if severe/persistent/bloody)</li>
          <li>If prolonged course or renal impairment: consider renal function monitoring when feasible</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>First-generation cephalosporin: good staphylococcal and streptococcal coverage for skin/soft tissue infections</li>
          <li>If diagnostics are limited and infection is not responding within 48–72 hours, reassess for alternate diagnosis, resistant organism, or need for escalation/evacuation</li>
          <li>Document start date, dose, planned duration, and allergy status clearly</li>
          <li>In penicillin-allergic patients: clarify history of reaction type (rash vs anaphylaxis) to guide safety of cephalosporin use</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (cephalexin capsules): <a href="https://pdf.hres.ca/dpd_pm/00067918.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00067918.PDF</a></li>
          <li>Medscape - Cephalexin reference: <a href="https://reference.medscape.com/drug/keflex-cephalexin-342508" target="_blank" rel="noopener">https://reference.medscape.com/drug/keflex-cephalexin-342508</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
